These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13660113)

  • 21. Exposure to environmental bacteria may have differing effects on tumour necrosis factor-alpha and interleukin-6-producing capacity in infancy.
    Lappalainen MH; Roponen M; Hyvärinen A; Nevalainen A; Laine O; Pekkanen J; Hirvonen MR
    Clin Exp Allergy; 2008 Sep; 38(9):1483-92. PubMed ID: 18631349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
    Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
    J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.
    Krinner EM; Hepp J; Hoffmann P; Bruckmaier S; Petersen L; Petsch S; Parr L; Schuster I; Mangold S; Lorenczewski G; Lutterbüse P; Buziol S; Hochheim I; Volkland J; Mølhøj M; Sriskandarajah M; Strasser M; Itin C; Wolf A; Basu A; Yang K; Filpula D; Sørensen P; Kufer P; Baeuerle P; Raum T
    Protein Eng Des Sel; 2006 Oct; 19(10):461-70. PubMed ID: 16868004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
    Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
    Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired tolerance to bacterial endotoxin: the pyrogen augmenting effect of serum.
    CLUFF LE; MULHOLLAND JH; SCHEDER EP
    Bull Johns Hopkins Hosp; 1959 Feb; 104(2):51-62. PubMed ID: 13618692
    [No Abstract]   [Full Text] [Related]  

  • 26. A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients.
    Amoureux MC; Hegyi E; Le D; Grandics P; Tong H; Szathmary S
    J Endotoxin Res; 2004; 10(2):85-95. PubMed ID: 15119999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the expression, purification and the anti-endotoxin activity of human endotoxin binding peptide and its mutant].
    Sun YL; Liu YS; Yang HJ; Wang CS; Ma JZ
    Zhonghua Shao Shang Za Zhi; 2006 Aug; 22(4):291-5. PubMed ID: 17175648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function.
    Wang ZQ; Xing WM; Fan HH; Wang KS; Zhang HK; Wang QW; Qi J; Yang HM; Yang J; Ren YN; Cui SJ; Zhang X; Liu F; Lin DH; Wang WH; Hoffmann MK; Han ZG
    J Immunol; 2009 Nov; 183(10):6646-56. PubMed ID: 19864597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin activity in whole blood measured by neutrophil chemiluminescence is applicable to canine whole blood.
    Kjelgaard-Hansen M; Wiinberg B; Aalbaek B; Olsen L; Harris D; Romaschin A; Kristensen AT; Jensen AL
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):477-85. PubMed ID: 17915322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro.
    Thaveeratitham P; Plengpanich W; Naen-Udorn W; Patumraj S; Khovidhunkit W
    J Endotoxin Res; 2007; 13(1):58-64. PubMed ID: 17621547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human growth hormone on intestinal translocation of bacteria and endotoxin in rats with obstructive jaundice.
    Yang ZW; Li JG; Mao XG; Sun B; Tong ZS; Sun HY; Li XR; Cong YP
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):445-9. PubMed ID: 16109534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of naturally occurring variants of HCV protease on the binding of different classes of protease inhibitors.
    Tong X; Guo Z; Wright-Minogue J; Xia E; Prongay A; Madison V; Qiu P; Venkatraman S; Velazquez F; Njoroge FG; Malcolm BA
    Biochemistry; 2006 Feb; 45(5):1353-61. PubMed ID: 16445277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide.
    Park CY; Jung SH; Bak JP; Lee SS; Rhee DK
    Biologicals; 2005 Sep; 33(3):145-51. PubMed ID: 16055344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin.
    Bucki R; Pastore JJ
    Eur J Haematol; 2006 Jun; 76(6):510-5. PubMed ID: 16529602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood.
    Kimura D; Totapally BR; Raszynski A; Ramachandran C; Torbati D
    Crit Care Med; 2008 Oct; 36(10):2823-7. PubMed ID: 18766096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response.
    Ertl OT; Wenz DC; Bouche FB; Berbers GA; Muller CP
    Arch Virol; 2003 Nov; 148(11):2195-206. PubMed ID: 14579178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in the development of neutralizing therapies for sepsis].
    Florencia Henning M; Garda H; Bakás L
    Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies.
    Kang SM; Quan FS; Huang C; Guo L; Ye L; Yang C; Compans RW
    Virology; 2005 Jan; 331(1):20-32. PubMed ID: 15582650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antigenic relationship between human blood proteins & blood proteins of various mammals].
    DEPIEDS R; RANQUE J; FAURE A
    C R Hebd Seances Acad Sci; 1958 Jan; 246(1):189-90. PubMed ID: 13511774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.